NASDAQ: ANEBAnebulo Pharmaceuticals Inc Stock Ownership - Who owns Anebulo Pharmaceuticals?
Insider buying vs selling
Have Anebulo Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Aron R. English | Director | 2024-12-23 | 10,101,010 | $0.99 | $10.00MBuy |
ANEB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ANEB insiders and whales buy or sell their stock.
ANEB Shareholders
What type of owners hold Anebulo Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Aron R. English | 48.98% | 20,121,828 | $47.49M | Insider |
| 22nw LP | 37.65% | 15,467,300 | $36.50M | Institution |
| Joseph F. Lawler | 29.21% | 12,000,000 | $28.32M | Insider |
| Nantahala Capital Management LLC | 7.39% | 3,036,325 | $7.17M | Institution |
| Mangrove Partners IM LLC | 6.15% | 2,525,252 | $5.96M | Institution |
| Morgan Stanley | 0.97% | 399,219 | $942.16k | Institution |
| Lvw Advisors LLC | 0.85% | 349,617 | $825.10k | Institution |
| Vanguard Group Inc | 0.53% | 215,951 | $509.64k | Institution |
| Geode Capital Management LLC | 0.50% | 205,720 | $485.50k | Institution |
| Ikarian Capital LLC | 0.38% | 157,720 | $372.22k | Institution |
ANEB vs Biotech Stocks
Anebulo Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.